{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:39:47Z","timestamp":1774924787639,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2017M3A9C8060390"],"award-info":[{"award-number":["NRF-2017M3A9C8060390"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2017R1A6A3A11031757"],"award-info":[{"award-number":["NRF-2017R1A6A3A11031757"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.canlet.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T10:28:59Z","timestamp":1597487339000},"page":"102-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Plasmacytoid dendritic cells regulate colitis-associated tumorigenesis by controlling myeloid-derived suppressor cell infiltration"],"prefix":"10.1016","volume":"493","author":[{"given":"Eun-Hye","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaewon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-hee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Eun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Na","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Uk","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Il","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Young","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jeong","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.08.007_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen recognition by the innate immune system","volume":"30","author":"Kumar","year":"2011","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12551-015-0187-1","article-title":"Structural aspects of nucleic acid-sensing toll-like receptors","volume":"8","author":"Ohto","year":"2016","journal-title":"Biophys Rev"},{"key":"10.1016\/j.canlet.2020.08.007_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874285800802010049","article-title":"Toll-like receptors and viruses: induction of innate antiviral immune responses","volume":"2","author":"Xagorari","year":"2008","journal-title":"Open Microbiol. J."},{"key":"10.1016\/j.canlet.2020.08.007_bib4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-like receptors in antiviral innate immunity","volume":"426","author":"Lester","year":"2014","journal-title":"J. Mol. Biol."},{"issue":"8","key":"10.1016\/j.canlet.2020.08.007_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/apm.12971","article-title":"Serum tlr2 and tlr4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome","volume":"127","author":"Paarnio","year":"2019","journal-title":"Apmis"},{"key":"10.1016\/j.canlet.2020.08.007_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/nu11061213","article-title":"Dietary inflammatory index and odds of colorectal cancer and colorectal adenomatous polyps in a case-control study from Iran","volume":"11","author":"Rafiee","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.canlet.2020.08.007_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000500226","article-title":"Utility of mesalazine in familial adenomatous polyposis: clinical report of reduction of polyp size in patients with ulcerative colitis, and safety examination in familial adenomatous polyposis patients","volume":"104","author":"Ishikawa","year":"2019","journal-title":"Pharmacology"},{"key":"10.1016\/j.canlet.2020.08.007_bib8","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1158\/1078-0432.CCR-16-2848","article-title":"Tumor-infiltrating and peripheral blood t-cell immunophenotypes predict early relapse in localized clear cell renal cell carcinoma","volume":"23","author":"Giraldo","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.08.007_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2019.04.014","article-title":"Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections","volume":"58","author":"Philip","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib10","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s12272-016-0822-9","article-title":"Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer","volume":"39","author":"Ko","year":"2016","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.canlet.2020.08.007_bib11","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/ijc.27974","article-title":"Blockade of myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells","volume":"132","author":"Hong","year":"2013","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2020.08.007_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fimmu.2018.00398","article-title":"Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression","volume":"9","author":"Fleming","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.03.009","article-title":"Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-beta production","volume":"44","author":"Yang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.08.007_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1067\/mai.2001.117928","article-title":"Corticosteroids depress ifn-alpha-producing plasmacytoid dendritic cells in human blood","volume":"108","author":"Shodell","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib15","doi-asserted-by":"crossref","first-page":"1749803","DOI":"10.1155\/2019\/1749803","article-title":"Pdc activation by tlr7\/8 ligand cl097 compared to tlr7 ligand imq or tlr9 ligand cpg","volume":"2019","author":"Wu","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.canlet.2020.08.007_bib16","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1073\/pnas.0708469104","article-title":"Conventional dendritic cells regulate the outcome of colonic inflammation independently of t cells","volume":"104","author":"Abe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2020.08.007_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1189\/jlb.0812397","article-title":"Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive\/tolerogenic cells: insight into the molecular mechanisms","volume":"93","author":"Demoulin","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2020.08.007_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1477-3163.78279","article-title":"The aom\/dss murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies","volume":"10","author":"De Robertis","year":"2011","journal-title":"J. Carcinog."},{"key":"10.1016\/j.canlet.2020.08.007_bib19","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1073\/pnas.1815016116","article-title":"Il-33\/regulatory t cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation","volume":"116","author":"Ameri","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2020.08.007_bib20","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.18632\/oncotarget.3682","article-title":"Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer","volume":"6","author":"Dufait","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.08.007_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-60761-421-0_10","article-title":"Cd8+, cd8-, and plasmacytoid dendritic cell generation in vitro using flt3 ligand","volume":"595","author":"Naik","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2020.08.007_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcancer.2019.05.001","article-title":"Risk of colorectal cancer in inflammatory bowel diseases","volume":"64","author":"Nadeem","year":"2019","journal-title":"Semin. Canc. Biol."},{"key":"10.1016\/j.canlet.2020.08.007_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.canlet.2020.08.007_bib24","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-induced tolerance and immune suppression depend on the c\/ebpbeta transcription factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2020.08.007_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2018.06.015","article-title":"Tlr7 polymorphism, sex and chronic hbv infection influence plasmacytoid dc maturation by tlr7 ligands","volume":"157","author":"Buschow","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.canlet.2020.08.007_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207422","article-title":"Tlr3 deficiency exacerbates the loss of epithelial barrier function during genital tract chlamydia muridarum infection","volume":"14","author":"Kumar","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2020.08.007_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature12599","article-title":"Paneth cells as a site of origin for intestinal inflammation","volume":"503","author":"Adolph","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.08.007_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.cell.2008.07.021","article-title":"Xbp1 links er stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease","volume":"134","author":"Kaser","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.08.007_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12967-015-0410-7","article-title":"Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer","volume":"13","author":"OuYang","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2020.08.007_bib31","first-page":"105","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease","volume":"13","author":"Kim","year":"2015","journal-title":"Int. Res."},{"key":"10.1016\/j.canlet.2020.08.007_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97022","article-title":"Cd38+ m-mdsc expansion characterizes a subset of advanced colorectal cancer patients","volume":"3","author":"Karakasheva","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2020.08.007_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.celrep.2015.06.024","article-title":"Ccl2 promotes colorectal carcinogenesis by enhancing polymorphonuclear myeloid-derived suppressor cell population and function","volume":"12","author":"Chun","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2020.08.007_bib35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fimmu.2019.00608","article-title":"Plasmacytoid dendritic cells provide protection against bacterial-induced colitis","volume":"10","author":"Rahman","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminoncol.2014.02.002","article-title":"Interferons and their stimulated genes in the tumor microenvironment","volume":"41","author":"Cheon","year":"2014","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2020.08.007_bib37","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nm.2830","article-title":"Silencing of irf7 pathways in breast cancer cells promotes bone metastasis through immune escape","volume":"18","author":"Bidwell","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2020.08.007_bib38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature06309","article-title":"Adaptive immunity maintains occult cancer in an equilibrium state","volume":"450","author":"Koebel","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.08.007_bib39","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1078-0432.CCR-10-2672","article-title":"Cpg blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice","volume":"17","author":"Zoglmeier","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.08.007_bib40","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1038\/s41467-019-12319-x","article-title":"Tissue-resident memory cd8(+) t cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells","volume":"10","author":"Menares","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.08.007_bib41","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3389\/fimmu.2018.03059","article-title":"Dendritic cells and cd8 t cell immunity in tumor microenvironment","volume":"9","author":"Fu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1673-8527(09)60061-8","article-title":"Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis","volume":"37","author":"Ye","year":"2010","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.canlet.2020.08.007_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.acr.2015.04.002","article-title":"Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment","volume":"128","author":"Parker","year":"2015","journal-title":"Adv. Canc. Res."},{"key":"10.1016\/j.canlet.2020.08.007_bib45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nri3726","article-title":"Interactions between innate and adaptive lymphocytes","volume":"14","author":"Gasteiger","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib46","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1158\/0008-5472.CAN-07-2354","article-title":"Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression","volume":"67","author":"Bunt","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.08.007_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-009-0622-8","article-title":"Gm-csf is one of the main breast tumor-derived soluble factors involved in the differentiation of cd11b-gr1- bone marrow progenitor cells into myeloid-derived suppressor cells","volume":"123","author":"Morales","year":"2010","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2020.08.007_bib48","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2020.08.007_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fimmu.2015.00523","article-title":"Paving the road to tumor development and spreading: myeloid-derived suppressor cells are ruling the fate","volume":"6","author":"Meirow","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002811","article-title":"Type i interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during candida infections","volume":"8","author":"Majer","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.canlet.2020.08.007_bib51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2016.00629","article-title":"The essential role of type i interferons in differentiation and activation of tumor-associated neutrophils","volume":"7","author":"Pylaeva","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib52","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.1502638","article-title":"Chronic type i ifn is sufficient to promote immunosuppression through accumulation of myeloid-derived suppressor cells","volume":"198","author":"Taleb","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib53","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/j.gastro.2006.06.017","article-title":"Cox-2 is regulated by toll-like receptor-4 (tlr4) signaling: role in proliferation and apoptosis in the intestine","volume":"131","author":"Fukata","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2020.08.007_bib54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccr.2013.10.009","article-title":"Cxcr2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis","volume":"24","author":"Katoh","year":"2013","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2020.08.007_bib55","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.4049\/jimmunol.177.8.5623","article-title":"Type i ifn modulates host defense and late hyperinflammation in septic peritonitis","volume":"177","author":"Weighardt","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2020.08.007_bib56","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1038\/ncomms14600","article-title":"Combined toll-like receptor 3\/7\/9 deficiency on host cells results in t-cell-dependent control of tumour growth","volume":"8","author":"Klein","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.08.007_bib57","doi-asserted-by":"crossref","first-page":"14355","DOI":"10.1128\/JVI.79.22.14355-14370.2005","article-title":"The toll-like receptor 7 (tlr7) agonist, imiquimod, and the tlr9 agonist, cpg odn, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520304201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520304201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:50:59Z","timestamp":1759593059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520304201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":57,"alternative-id":["S0304383520304201"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.08.007","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmacytoid dendritic cells regulate colitis-associated tumorigenesis by controlling myeloid-derived suppressor cell infiltration","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}